+ Filter
Loading...
Hypoxic Liver Cancer
Loading...Anti-Hypoxic Liver Cancer Products
-
- Species Reactivity: Human
- Type: Human IgG
- Application: IHC
- Human Anti-Hypoxic Liver Cancer Antibody (clone H103), mRNA (HPAB-M0103-YC-mRNA)
-
- Species Reactivity: Human
- Human Anti-Hypoxic Liver Cancer Recombinant Antibody (clone H103); scFv Fragment (HPAB-M0103-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: IHC
- Human Anti-Hypoxic Liver Cancer Recombinant Antibody (clone H103); Fab Fragment (HPAB-M0103-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: IHC
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
The tumor dormancy results in cell activation is a major source of cancer recurrence and metastasis. Tumor dormancy phenomenon is very common in clinical, primary cancer or dormant tumor foci often shows many cancer tissue or cells with varying degrees of hypoxia characteristics. For patients with liver cancer, many people in primary liver cancer a few months or even weeks, the entire liver, lung or bone appearances micro / small metastases. Such tumor cells proliferate rapidly dormant is activated, resulting in rapid deterioration of recurrence and metastasis, disease.


